TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
MEDP

Medpace Holdings Inc

Healthcare · Diagnostics & Research

618.90$ -0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow MEDP
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
25.9% 23.9% 21.8% 22.3% 22.2% 23.4% 27.9% 23.1% 26.6% 23.0% 28.9% 28.2%
23.5% 19.4% 13.8% 10.7% 5.5% 2.7% 2.1% 1.8% 1.5% 1.4% 1.4% 1.1%
4.4% 6.2% 2.3% 1.0% 0.9% 2.4% 1.5% 1.3% 1.5% 1.1% 1.2% 1.4%
0.9% 5.2% 2.5% -0.4% 1.7% 3.8% 1.5% -1.9% -0.2% – – –
-3.1% 1.0% 1.7% 3.0% 5.6% 4.1% 7.2% 5.8% 7.3% 5.6% 7.5% 3.8%
1.8% 1.8% 3.2% 2.8% 2.3% 2.1% 3.4% 2.5% 2.5% 1.9% 1.7% 1.2%
-313.2% -1.8% -3.2% -2.8% -2.4% -2.2% -3.4% -2.7% -2.7% -1.8% -1.3% -1.2%
– – 0.0% 0.0% – – – – 1.5% 0.6% – –
142.7% 0.2% -0.6% -35.7% 0.4% 0.8% -10.6% -5.4% -58.1% -7.6% -8.1% -36.3%
164.7% -32.7% -54.0% 12.8% -20.4% -9.3% 5.4% 4.4% 3.4% -2.7% 0.0% 0.0%
304.2% -32.4% -13.8% -22.4% -20.1% -8.6% -8.9% -3.9% -53.1% -9.7% -7.3% -34.0%
19.1% -10.5% 4.7% -2.5% -0.5% 12.6% 15.8% 16.1% -29.7% 11.5% 20.1% -6.8%
24.1% 22.1% 18.5% 19.5% 19.9% 21.4% 24.6% 20.6% 24.1% 21.0% 27.1% 26.9%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?